Summary
324.95 -0.96(-0.29%)07/03/2024
Cigna Corp. (CI)
Cigna Corp. (CI)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.30 | -3.83 | -4.84 | -10.00 | 7.01 | 16.98 | 107.78 | 14,603.62 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 324.95 | |
| Open | 327.42 | |
| High | 327.42 | |
| Low | 321.69 | |
| Volume | 698,279 | |
| Change | -0.97 | |
| Change % | -0.30 | |
| Avg Volume (20 Days) | 877,323 | |
| Volume/Avg Volume (20 Days) Ratio | 0.80 | |
| 52 Week Range | 253.95 - 365.71 | |
| Price vs 52 Week High | -11.15% | |
| Price vs 52 Week Low | 27.96% | |
| Range | -0.75 | |
| Gap Up/Down | 0.09 | |
Fundamentals | ||
| Market Capitalization (Mln) | 92,446 | |
| EBIDTA | 9,216,000,000 | |
| PE Ratio | 28.5800 | |
| PEG Ratio | 0.8920 | |
| WallStreet Target Price | 391.24 | |
| Book Value | 144.9010 | |
| Earnings Per Share | 12.1900 | |
| EPS Estimate Current Quarter | 6.2200 | |
| EPS Estimate Next Quarter | 6.9300 | |
| EPS Estimate Current Year | 28.5100 | |
| EPS Estimate Next Year | 32.1300 | |
| Diluted EPS (TTM) | 12.1900 | |
| Revenues | ||
| Profit Marging | 0.0177 | |
| Operating Marging (TTM) | 0.0081 | |
| Return on asset (TTM) | 0.0308 | |
| Return on equity (TTM) | 0.0897 | |
| Revenue TTM | 204,145,000,448 | |
| Revenue per share TTM | 700.1300 | |
| Quarterly Revenue Growth (YOY) | 0.1930 | |
| Quarterly Earnings Growth (YOY) | -0.1050 | |
| Gross Profit (TTM) | 22,981,000,000 | |
| Dividends | ||
| Dividend Share | 5.0900 | |
| Dividend Yield | 0.0161 | |
| Valuations | ||
| Trailing PE | 28.5800 | |
| Forward PE | 12.3153 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.1468 | |
| Revenue Enterprise Value | 0.6268 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 284,073,984 | |
| Shares Float | 282,682,038 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 1.55 | |
| Institutions (%) | 93.21 | |
07/03 09:00 EST - prnewswire.com
The Cigna Group's Second Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn. , July 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day.
The Cigna Group's Second Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn. , July 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day.
06/27 10:51 EST - zacks.com
Why Cigna (CI) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Cigna (CI) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
06/26 14:40 EST - benzinga.com
Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says
Piper Sandler has initiated coverage on Cigna Corporation CI, a diversified managed care and healthcare delivery organization specializing in commercial insurance markets and pharmacy services.
Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says
Piper Sandler has initiated coverage on Cigna Corporation CI, a diversified managed care and healthcare delivery organization specializing in commercial insurance markets and pharmacy services.
06/26 10:56 EST - zacks.com
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
06/21 06:00 EST - investorplace.com
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Fundamentally, the case for strong buy healthcare stocks really sells itself. First off, let's discuss the underlying sector.
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Fundamentally, the case for strong buy healthcare stocks really sells itself. First off, let's discuss the underlying sector.
06/20 06:00 EST - prnewswire.com
Express Scripts by Evernorth Members Paid Less for Prescriptions in 2023 Despite Drug Price Increases
Members with employer-sponsored insurance saw about a 1% decrease in out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply ST. LOUIS, Mo.
Express Scripts by Evernorth Members Paid Less for Prescriptions in 2023 Despite Drug Price Increases
Members with employer-sponsored insurance saw about a 1% decrease in out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply ST. LOUIS, Mo.
06/17 14:20 EST - zacks.com
Compelling Reasons to Hold on to Cigna (CI) Stock for Now
Cigna (CI) remains well-poised for growth on the back of improved pharmacy revenues in its Evernorth unit. Solid cash-generating abilities also enable it to tactically deploy capital.
Compelling Reasons to Hold on to Cigna (CI) Stock for Now
Cigna (CI) remains well-poised for growth on the back of improved pharmacy revenues in its Evernorth unit. Solid cash-generating abilities also enable it to tactically deploy capital.
06/16 09:00 EST - seekingalpha.com
Our Top 10 Dividend Growth Stocks - June 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.
Our Top 10 Dividend Growth Stocks - June 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.
06/13 12:01 EST - businesswire.com
Zero Emission Line Haul Locomotives for $1.1 Million? OptiFuel Puts Renewable Fuel Credits to Smart Use for the Benefit of US Railroads
BEAUFORT, S.C.--(BUSINESS WIRE)--OptiFuel's Zero Emission Locomotives fueled by RNG = lower cost than diesel. Their pioneering Locomotive-as-a-Service (LAAS™) Program = affordability.
Zero Emission Line Haul Locomotives for $1.1 Million? OptiFuel Puts Renewable Fuel Credits to Smart Use for the Benefit of US Railroads
BEAUFORT, S.C.--(BUSINESS WIRE)--OptiFuel's Zero Emission Locomotives fueled by RNG = lower cost than diesel. Their pioneering Locomotive-as-a-Service (LAAS™) Program = affordability.
06/11 16:24 EST - seekingalpha.com
The Cigna Group (CI) Management presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
The Cigna Group (NYSE:CI ) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 10:00 AM ET Company Participants Brian Evanko - CFO Conference Call Participants Nathan Rich - Goldman Sachs Nathan Rich Great. Good morning, everyone.
The Cigna Group (CI) Management presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
The Cigna Group (NYSE:CI ) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 10:00 AM ET Company Participants Brian Evanko - CFO Conference Call Participants Nathan Rich - Goldman Sachs Nathan Rich Great. Good morning, everyone.
06/11 15:03 EST - seekingalpha.com
Cigna: Will Benefit From Lower Medicaid Enrollments
Cigna Group's dividend growth potential and strong financial performance make it worth considering for long-term investors. The company's revenue for the quarter grew by 23.3% year over year, with strong growth in its Evernorth Health Services segment. Management's outlook projects a 6% to 9% estimated growth rate for the company, with potential for increased market share and higher revenues.
Cigna: Will Benefit From Lower Medicaid Enrollments
Cigna Group's dividend growth potential and strong financial performance make it worth considering for long-term investors. The company's revenue for the quarter grew by 23.3% year over year, with strong growth in its Evernorth Health Services segment. Management's outlook projects a 6% to 9% estimated growth rate for the company, with potential for increased market share and higher revenues.
06/11 10:46 EST - reuters.com
UnitedHealth hack impacted outpatient claims for Cigna - GS conference
Cigna's CFO Brian Evanko said the company's "outpatient dynamic" was impacted by the Change Healthcare hack which disrupted claims during the first quarter of 2024.
UnitedHealth hack impacted outpatient claims for Cigna - GS conference
Cigna's CFO Brian Evanko said the company's "outpatient dynamic" was impacted by the Change Healthcare hack which disrupted claims during the first quarter of 2024.
05/28 08:48 EST - marketbeat.com
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023.
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023.
05/28 06:00 EST - businesswire.com
OpsMill Transforms Infrastructure Automation with Beta Release of Open Source Infrahub
PARIS--(BUSINESS WIRE)--OpsMill, a pioneer in infrastructure and network automation, today announced the beta release of its open source Infrahub platform. Infrahub unifies previously disparate automation capabilities into a single platform, enabling IT teams to transform all their data center, cloud, network, and security infrastructure operations with scalable and consumable automation. “I've spent years building automation systems for infrastructure and network management across a variety of.
OpsMill Transforms Infrastructure Automation with Beta Release of Open Source Infrahub
PARIS--(BUSINESS WIRE)--OpsMill, a pioneer in infrastructure and network automation, today announced the beta release of its open source Infrahub platform. Infrahub unifies previously disparate automation capabilities into a single platform, enabling IT teams to transform all their data center, cloud, network, and security infrastructure operations with scalable and consumable automation. “I've spent years building automation systems for infrastructure and network management across a variety of.
05/27 12:51 EST - zacks.com
Cigna's (CI) Express Scripts Collaborates With CPESN USA
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
Cigna's (CI) Express Scripts Collaborates With CPESN USA
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
05/23 08:00 EST - prnewswire.com
Express Scripts enhances strategies to support access to care at independent pharmacies
Based on guidance from its Independent Pharmacy Advisory Committee, Express Scripts will collaborate with CPESN ® USA through its IndependentRx initiative ST. LOUIS , May 23, 2024 /PRNewswire/ -- Express Scripts, the pharmacy benefits services business of The Cigna Group's (NYSE: CI) Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
Express Scripts enhances strategies to support access to care at independent pharmacies
Based on guidance from its Independent Pharmacy Advisory Committee, Express Scripts will collaborate with CPESN ® USA through its IndependentRx initiative ST. LOUIS , May 23, 2024 /PRNewswire/ -- Express Scripts, the pharmacy benefits services business of The Cigna Group's (NYSE: CI) Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
05/21 09:00 EST - prnewswire.com
The Cigna Group Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
BLOOMFIELD, Conn. , May 21, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, President and CEO of Cigna Healthcare, will present at Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami, FL.
The Cigna Group Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
BLOOMFIELD, Conn. , May 21, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, President and CEO of Cigna Healthcare, will present at Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami, FL.
05/20 07:28 EST - https://www.defenseworld.net
Meridian Wealth Management LLC Sells 400 Shares of Teck Resources Limited (NYSE:TECK)
Meridian Wealth Management LLC trimmed its position in shares of Teck Resources Limited (NYSE:TECK – Free Report) (TSE:TECK) by 5.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,104 shares of the basic materials company’s stock after selling 400 shares during the period. Meridian Wealth Management LLC’s holdings in Teck Resources were worth $301,000 at the end of the most recent reporting period. Other large investors also recently modified their holdings of the company. Wealthsource Partners LLC grew its position in shares of Teck Resources by 4.0% during the third quarter. Wealthsource Partners LLC now owns 7,747 shares of the basic materials company’s stock worth $334,000 after purchasing an additional 300 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of Teck Resources by 2.9% during the third quarter. Shell Asset Management Co. now owns 13,649 shares of the basic materials company’s stock worth $590,000 after acquiring an additional 386 shares during the last quarter. Allworth Financial LP grew its stake in Teck Resources by 17.9% during the third quarter. Allworth Financial LP now owns 2,558 shares of the basic materials company’s stock valued at $110,000 after acquiring an additional 388 shares in the last quarter. Cigna Investments Inc. New increased its holdings in Teck Resources by 4.6% in the 4th quarter. Cigna Investments Inc. New now owns 8,800 shares of the basic materials company’s stock valued at $374,000 after acquiring an additional 391 shares during the last quarter. Finally, Kestra Advisory Services LLC lifted its stake in Teck Resources by 4.1% in the 3rd quarter. Kestra Advisory Services LLC now owns 11,511 shares of the basic materials company’s stock worth $496,000 after purchasing an additional 455 shares in the last quarter. Hedge funds and other institutional investors own 78.06% of the company’s stock. Teck Resources Trading Up 3.8 % TECK opened at $53.79 on Monday. The company has a quick ratio of 0.86, a current ratio of 1.49 and a debt-to-equity ratio of 0.20. The stock’s fifty day moving average is $47.46 and its two-hundred day moving average is $41.76. The company has a market capitalization of $27.51 billion, a P/E ratio of 23.80, a PEG ratio of 11.92 and a beta of 1.12. Teck Resources Limited has a 52 week low of $34.38 and a 52 week high of $53.84. Teck Resources (NYSE:TECK – Get Free Report) (TSE:TECK) last posted its quarterly earnings results on Thursday, April 25th. The basic materials company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.31). Teck Resources had a net margin of 10.59% and a return on equity of 7.52%. The business had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $2.99 billion. Analysts forecast that Teck Resources Limited will post 2.18 earnings per share for the current year. Teck Resources Cuts Dividend The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 17th will be given a $0.0911 dividend. This represents a $0.36 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Monday, June 17th. Teck Resources’s payout ratio is 16.37%. Analysts Set New Price Targets Several equities analysts have weighed in on the company. Benchmark raised their price target on Teck Resources from $50.00 to $52.00 and gave the company a “buy” rating in a report on Monday, April 8th. Morgan Stanley restated an “overweight” rating and issued a $55.00 price target on shares of Teck Resources in a research report on Thursday, April 11th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Teck Resources from $44.00 to $50.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $57.86. Get Our Latest Stock Report on Teck Resources Teck Resources Profile (Free Report) Teck Resources Limited engages in exploring for, acquiring, developing, and producing natural resources in Asia, Europe, and North America. The company operates through Steelmaking Coal, Copper, Zinc, and Energy segments. Its principal products include copper, zinc, steelmaking coal, and blended bitumen.
Meridian Wealth Management LLC Sells 400 Shares of Teck Resources Limited (NYSE:TECK)
Meridian Wealth Management LLC trimmed its position in shares of Teck Resources Limited (NYSE:TECK – Free Report) (TSE:TECK) by 5.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,104 shares of the basic materials company’s stock after selling 400 shares during the period. Meridian Wealth Management LLC’s holdings in Teck Resources were worth $301,000 at the end of the most recent reporting period. Other large investors also recently modified their holdings of the company. Wealthsource Partners LLC grew its position in shares of Teck Resources by 4.0% during the third quarter. Wealthsource Partners LLC now owns 7,747 shares of the basic materials company’s stock worth $334,000 after purchasing an additional 300 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of Teck Resources by 2.9% during the third quarter. Shell Asset Management Co. now owns 13,649 shares of the basic materials company’s stock worth $590,000 after acquiring an additional 386 shares during the last quarter. Allworth Financial LP grew its stake in Teck Resources by 17.9% during the third quarter. Allworth Financial LP now owns 2,558 shares of the basic materials company’s stock valued at $110,000 after acquiring an additional 388 shares in the last quarter. Cigna Investments Inc. New increased its holdings in Teck Resources by 4.6% in the 4th quarter. Cigna Investments Inc. New now owns 8,800 shares of the basic materials company’s stock valued at $374,000 after acquiring an additional 391 shares during the last quarter. Finally, Kestra Advisory Services LLC lifted its stake in Teck Resources by 4.1% in the 3rd quarter. Kestra Advisory Services LLC now owns 11,511 shares of the basic materials company’s stock worth $496,000 after purchasing an additional 455 shares in the last quarter. Hedge funds and other institutional investors own 78.06% of the company’s stock. Teck Resources Trading Up 3.8 % TECK opened at $53.79 on Monday. The company has a quick ratio of 0.86, a current ratio of 1.49 and a debt-to-equity ratio of 0.20. The stock’s fifty day moving average is $47.46 and its two-hundred day moving average is $41.76. The company has a market capitalization of $27.51 billion, a P/E ratio of 23.80, a PEG ratio of 11.92 and a beta of 1.12. Teck Resources Limited has a 52 week low of $34.38 and a 52 week high of $53.84. Teck Resources (NYSE:TECK – Get Free Report) (TSE:TECK) last posted its quarterly earnings results on Thursday, April 25th. The basic materials company reported $0.56 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.31). Teck Resources had a net margin of 10.59% and a return on equity of 7.52%. The business had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $2.99 billion. Analysts forecast that Teck Resources Limited will post 2.18 earnings per share for the current year. Teck Resources Cuts Dividend The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 17th will be given a $0.0911 dividend. This represents a $0.36 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Monday, June 17th. Teck Resources’s payout ratio is 16.37%. Analysts Set New Price Targets Several equities analysts have weighed in on the company. Benchmark raised their price target on Teck Resources from $50.00 to $52.00 and gave the company a “buy” rating in a report on Monday, April 8th. Morgan Stanley restated an “overweight” rating and issued a $55.00 price target on shares of Teck Resources in a research report on Thursday, April 11th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Teck Resources from $44.00 to $50.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $57.86. Get Our Latest Stock Report on Teck Resources Teck Resources Profile (Free Report) Teck Resources Limited engages in exploring for, acquiring, developing, and producing natural resources in Asia, Europe, and North America. The company operates through Steelmaking Coal, Copper, Zinc, and Energy segments. Its principal products include copper, zinc, steelmaking coal, and blended bitumen.
05/20 01:36 EST - https://www.defenseworld.net
The Cigna Group (NYSE:CI) and NeueHealth (NYSE:NEUE) Financial Analysis
The Cigna Group (NYSE:CI – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Earnings and Valuation This table compares The Cigna Group and NeueHealth’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Cigna Group $195.27 billion 0.49 $5.16 billion $12.18 27.81 NeueHealth $1.16 billion 0.04 -$1.15 billion ($130.73) -0.05 The Cigna Group has higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks. Profitability This table compares The Cigna Group and NeueHealth’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets The Cigna Group 1.76% 17.24% 5.09% NeueHealth -89.78% -5.62% 2.57% Institutional & Insider Ownership 87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 64.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Risk and Volatility The Cigna Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Analyst Ratings This is a summary of current ratings and target prices for The Cigna Group and NeueHealth, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Cigna Group 0 2 10 1 2.92 NeueHealth 0 1 0 0 2.00 The Cigna Group currently has a consensus price target of $366.14, indicating a potential upside of 8.10%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 33.56%. Given NeueHealth’s higher probable upside, analysts clearly believe NeueHealth is more favorable than The Cigna Group. Summary The Cigna Group beats NeueHealth on 12 of the 15 factors compared between the two stocks. About The Cigna Group (Get Free Report) The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut. About NeueHealth (Get Free Report) NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
The Cigna Group (NYSE:CI) and NeueHealth (NYSE:NEUE) Financial Analysis
The Cigna Group (NYSE:CI – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Earnings and Valuation This table compares The Cigna Group and NeueHealth’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Cigna Group $195.27 billion 0.49 $5.16 billion $12.18 27.81 NeueHealth $1.16 billion 0.04 -$1.15 billion ($130.73) -0.05 The Cigna Group has higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks. Profitability This table compares The Cigna Group and NeueHealth’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets The Cigna Group 1.76% 17.24% 5.09% NeueHealth -89.78% -5.62% 2.57% Institutional & Insider Ownership 87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 64.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Risk and Volatility The Cigna Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Analyst Ratings This is a summary of current ratings and target prices for The Cigna Group and NeueHealth, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Cigna Group 0 2 10 1 2.92 NeueHealth 0 1 0 0 2.00 The Cigna Group currently has a consensus price target of $366.14, indicating a potential upside of 8.10%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 33.56%. Given NeueHealth’s higher probable upside, analysts clearly believe NeueHealth is more favorable than The Cigna Group. Summary The Cigna Group beats NeueHealth on 12 of the 15 factors compared between the two stocks. About The Cigna Group (Get Free Report) The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut. About NeueHealth (Get Free Report) NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
05/18 09:00 EST - seekingalpha.com
Our Top 10 Dividend Growth Stocks - May 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.
Our Top 10 Dividend Growth Stocks - May 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It offers a step-by-step guide on structuring a portfolio based on this strategy.